Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.5M | 29.2M | 24.1M | 23.5M |
| Cost of revenue | 0 | 8.0M | 4.4M | 9.7M |
| Gross profit | 10.5M | 21.2M | 19.7M | 13.7M |
| Operating expense | ||||
| Research & development | 30.5M | 28.7M | 35.0M | 29.7M |
| Selling general and admin | 24.3M | 17.1M | 19.0M | 20.5M |
| Other operating expenses | — | — | — | — |
| Operating income | -44.4M | -24.7M | -34.3M | -36.5M |
| Non operating interest income | ||||
| Income | 2.9M | 2.9M | 3.4M | 3.9M |
| Expense | 5.0M | 10.2M | 6.0M | 6.4M |
| Other income expense | 97K | 38.9M | -166K | -13.3M |
| Pretax income | -46.4M | 7.0M | -37.0M | -52.3M |
| Tax provision | 52K | -259K | 9K | 46K |
| Net income | -50.9M | 7.3M | -37.1M | -52.4M |
| Basic EPS | -0.2 | 0.0 | -0.2 | -0.3 |
| Diluted EPS | -0.2 | 0.0 | -0.2 | -0.3 |
| Basic average shares | 210.9M | 209.7M | 209.2M | 208.8M |
| Diluted average shares | 210.9M | 213.6M | 209.2M | 208.8M |
| EBITDA | -40.8M | -21.5M | -30.0M | -31.2M |
| Net income from continuing op. | -50.9M | 7.3M | -37.1M | -52.4M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |